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1. Introduction
Osteoarthritis (OA) is one of the most disabling diseases in developed countries and is re‐
sponsible for significant disability in over 43 million people worldwide, 27 million of whom
are 60 years of age or older [1]. Age is the strongest predictor of the development and pro‐
gression of osteoarthritis, as such the number of people suffering with OA is expected to
continue to increase over the coming years due to the ageing population [2]. Other predic‐
tors associated with OA include; gender, obesity, physical inactivity, smoking, excess alco‐
hol and injuries [2].
Total joint replacement is the treatment of choice (among suitably ‘fit’ candidates) for end-
stage OA [3]. It is a high-cost and high-volume procedure, which dominates surgical waiting
lists and this is expected to become critical with the rapidly ageing population [4]. The num‐
ber of hip and knee replacement being performed each year has risen markedly over the
past decade in most OECD countries [2]. On average, the rate of hip replacement has in‐
creased by over 25% and the rate of knee replacement has nearly doubled. While joint re‐
placement surgery is mainly carried out in people aged 60 and over, the rate of surgery is
also increasing in younger people due to the increasing prevalence of obesity, advances in
surgery and greater patient demand.
Many studies have confirmed the beneficial impact of TJR on pain, disability and quality of
life [5, 6]. However, surgery is not without risk. In the immediate post-operative period,
there is a small but important risk of severe complications [7-9] and in the longer term there
is the risk of prosthesis failure, primarily through loosening, resulting in the need for com‐
plex revision surgery [10]. While the majority can expect improvements in pain and function
in the intermediate period, there is a minority who remain dissatisfied after TJR and this is
despite procedurally excellent outcomes. There are a number of risk factors for continuing
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pain and disability after surgery and given the increasing demand for TJR, understanding
more about the determinants of good and bad outcomes has become an imperative.
This chapter provides an overview of baseline patient characteristics and predictors associ‐
ated with pain and function following total joint replacement.
2. Incidence
The incidence of dissatisfaction or suboptimal outcome following total joint replacement var‐
ies in the literature. Quantifying the influence of a single patient factor on the functional and
quality of life outcomes in joint replacement is a complex process. Variations in reporting may
in part be due to the range of instruments used to measure patient centred outcomes and the
lack of consensus and consistency amongst health professionals in how these tools are used
[11-14]. Furthermore, to understand the complexities of what contributes to a suboptimal out‐
come, large data sets with samples representative of the total study population and extensive
follow-up are essential, however this is a labour intensive and challenging process.
In 1998 our institution established a joint replacement registry to respond to this issue and to
contribute to our understanding of what constitutes and predicts a good versus poor out‐
come following TJR. The St Vincent’s Total Joint Replacement Registry (SVHM JRR) current‐
ly contains over 8000 procedures undertaken in over 7000 consecutive patients, and grows
by approximately 800 procedures each year. Data include patient demographics, diagnoses,
and type of surgery, prostheses, co-morbidities and peri-operative interventions, and an ex‐
tensive range of outcomes including death, re-hospitalisation and complications. The regis‐
try includes marginalised and disadvantaged groups and is characterised by i) cultural and
linguistic diversity (15% from a non-English speaking background representing over 20 lan‐
guages); ii) 15% rural representation; and iii) socio-economic diversity (20% are ranked as
living in the most “disadvantaged” socio-economic areas (Australian Bureau of Statistics
[15]). Since 2006, we have obtained near complete (> 99%) 12 month follow-up of our cohort.
Pain and functional outcomes as well as quality of life (QoL) are measured using validated
surveys including; the Harris Hip Score [13, 16], the International Knee Society Score[17, 18]
and Short Form Health Survey[12, 13, 19].
From our registry and that of the literature, dissatisfaction (variously measured) is as high
as 50% among patients undergoing total joint replacement [20-25]. The level of dissatisfac‐
tion amongst recipients of hip and knee replacement is considerably different with a much
higher rate of satisfaction reported amongst patients undergoing hip than knee replacement.
2.1. Pain
Chronic pain is a major global health care problem reported in 1 in 5 adults. The major caus‐
es of non-cancer chronic pain are; arthritis (40%) and surgery or injury (25%). For many,
chronic pain substantially impairs daily physical activities, social activities and ability to en‐
joy life [26]. It carries a major economic burden with estimated costs running into billions in
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many OECD countries; US$635 billion in America [27], EUR$32 billion in Sweden [28] and
AU$34 billion in Australia [29].
Chronic disabling pain is the primary indicator for recommending TJR in those with radio‐
graphic evidence of arthritis. For those that present with early disease, conservative treat‐
ment modalities including physical and pharmacological therapies are the first line of
treatment [30, 31] however arthritis is a progressive disease and non-surgical modalities can
effectively delay but not negate the need for eventual surgical intervention. Surgical inter‐
ventions such as arthroscopy, bone marrow stimulation or osteotomy, may be recommend‐
ed in carefully selected patients, however TJR remains the most effective and cost effective
intervention for relieving pain and restoring function in suitably fit patients [32, 33]
Total joint replacement is a major surgical procedure that requires multidisciplinary input
prior to and after surgery to ensure the best possible outcome. Recovery from surgery is op‐
timized with the inclusion of rehabilitation programs which are tailored to restore mobility
and independence [34]. Time to recovery can vary following TJR and most patients will re‐
port substantial gains between 3 to 6 months after surgery. Patients undergoing THR report
faster recovery in terms of both pain and function, with significant improvements occurring
within the first 3 months of surgery [35]. In comparison patients undergoing TKR are more
likely to report improvement between 3 to 6 months [36, 37]. Overall a continuing pattern of
improvement can be observed up to 12 months following surgery [5, 38].
While on average a majority of patients report an improvement in pain following total joint
replacement [39, 40] for a substantial number of individuals the level of improvement is sub‐
optimal or does not meet expectation at 12 months or more after surgery. In total knee re‐
placement ongoing pain has been reported in as many as 53% of patients and for hip
replacement the incidence is as high as 38% (Table 1).
The causes of ongoing pain following TJR are not clearly understood. Recent literature re‐
ports a high prevalence of features of pain sensitisation in knee OA patients. Wylde et al
(2011) identified 70% of patients as having various somatosensory abnormalities in a study
of 117 knee OA patients [44]. Hochman et al (2011) reported neuropathic symptoms in 28%
of older adults with chronic symptomatic knee OA [52]. Ohtori et al (2012) reported similar
findings with neuropathic symptoms in as many as 20.6% of patients with radiographically
confirmed knee OA [53]. These mechanisms of pain are not necessarily addressed by under‐
going joint replacement.
Recent trials of the use of second-generation antiepileptic drugs (AED’s), which are com‐
monly used to treat neuropathic pain however, report mixed results in TJR studies. Both Ga‐
bapentin and Pregalbin use are associated with a reduction in post-operative opioid
consumption following knee replacement [54, 55]. A randomized controlled trial comparing
pre-operative Pregalbin to placebo has also reported a significant reduction in neuropathic
pain at 6 months post TKR [54]. In contrast, Gabapentin had no effect on post-operative
opioid consumption or pain scores at 6 months following total hip replacement [56]. While
pre-operative Pregalbin has shown to reduce post-operative opioid consumption following
THR, the longer term effects on post surgery pain have not been reported.
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Overall higher rates of persistent pain are reported after knee replacement as compared to hip
replacement (Table 1). Features of pain sensitisation and neuropathic type symptoms are also
predominately reported in knee OA patients. This may explain the differences in response to
AED’s between hip and knee replacement recipients and is an indication that the underlying
mechanisms of persistent pain following surgery differ according to the surgical site.
Author Cohort Follow-up Pain Measure Incidence of Ongoing Pain
Liu
et al 2012 [41]
TJR = 1030 Minimum 1 year
32% response rate
McGill Pain
Questionnaire [42]
Persistent pain
THR = 38.0%
TKR = 53.0%
Dowsey et al
2012 [40]
TKR = 478 99.4% at 1 year
93.5% at 2 years
IKSS [43] pain Moderate to severe pain
29.5% at 12 months
30.6% at 2 years
Wylde et al 2011
[44]
THR = 909
TKR = 860
3 to 4 years
73.0% hip and knee
WOMAC [45] pain Persistent pain
THR = 27.0%
TKR = 44.0%
Singh & Lewallen
2010 [46]
THR =
9,154 (2yrs)
6,243 (5yrs)
62.3% at 2 years
52.7 at 5 years
Mayo [47] Hip Score Moderate to severe pain
8.1% at 2 years
10.6% at 5 years
Czurda et al
2010 [5, 48]
TKR = 411 18 to 42 months
80.3%
WOMAC [45] pain Knee pain
13.9%
Wylde et al
2009 [49]
THR = 1,534
TKR = 857
5 to 8 years
72.5% hip
71.5% knee
Oxford [50]
pain
Moderate to severe pain
THR = 13.0%
TKR = 26.0%
Baker et al
2007 [51]
TKR = 9417 87.4% at 1 year Oxford [50] pain Persistent pain
19.8% at 1 year
(IKSS – International Knee Society Score, WOMAC – Western Ontario and McMaster Universities Arthritis Index)
Table 1. Incidence of self reported pain > 12 months following TJR
2.2. Function
While arthritis accounts for 40% of non-cancer chronic pain it is the leading cause of disabili‐
ty in most developed countries. [57-59]. For many sufferers of arthritis even the most basic
daily activities such as dressing, walking and stair climbing are substantially restricted. Pain
and deformity associated with the progression of arthritis are the main contributors to im‐
peding function and activity. As such joint replacement surgery that results in amelioration
of pain and correction of deformity should lead to improved function and activity participa‐
tion. However poor function and difficulty with daily activities have been reported up to
51% of TJR recipients, (Table 2).
Arthroplasty - Update70
A decrease in activity participation outside those required for basic daily functioning has al‐
so been noted in a proportion of patients who have undergone TJR. Wylde et.al interviewed
56 hip and 60 knee replacement patients about their leisure activities [60]. They reported
that THR patients participated in 209 leisure activities but rated 82% of these activities as
difficult to perform prior to surgery and TKR patients participated in 171 leisure activities
86% of which were rated as difficult to perform prior to surgery due to joint problems. At 1
year post surgery THR patients still rated 25% of leisure activities as difficult to perform and
TKR patients rate 32% of leisure activities difficult to perform. In a larger study Groen et.al
measured adherence to an activity regimen recommended to maintain health in patients
who underwent total knee replacement and found that 42% of patients were not active
enough to maintain their health and fitness [61].
Author Cohort Follow-up Functional Measure Incidence of Functional
Impairment
Dowsey et al
2012 [40]
TKR = 478 99.4% at 1 year
93.5% at 2 years
IKSS [43] function Poor function
48.9% at 12 months
50.7% at 2 years
Wylde et al
2009 [49]
THR = 1,534
TKR = 857
5 to 8 years
72.5% hip
71.5% knee
Oxford [50]
function
Extreme difficulty with individual
activities
THR = 5% to 17%
TKR = 7% to 24%
Franklin et al
2008 [175]
TKJR = 17270 46.6% at 1 year SF12 PCS [12]
function
Function score worse than
baseline = 19.0%
Lubbeke et al
2007 [62]
THR = 435 4 to 6 years
80.2%
HHS [16]
function
Fair or poor function
9.0%
Nilsdotter et al
2003 [25]
THR = 211 26 to 65 months
94%
OARSI Criteria [63] No improvement in function =
8.7%
Singh & Lewallen
2010 [64]
THR =
9,154 (2yrs)
6,243 (5yrs)
62.3% at 2 years
52.7% at 5 years
Mayo [47] Hip Score Moderate to severe activity
limitation
30% at 2 years
35% at 5 years
Singh et al
(2010) [126]
TKR =
10,957 (2 yrs)
7,404 (5yrs)
65.0% at 2 years
57.0% at 5 years
IKSS [43]
function
Moderate to severe activity
limitation
20.7% at 2 years
27.1% at 5 years
(SF-12 PCS – Short Form 12 Physical Component Summary, HHS – Harris Hip Score, OARSI – Osteoarthritis Research
Society International
Table 2. Incidence of self reported functional impairment > 12 months following TJR
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As function and activity levels depends on all other joints and systems, not just the joint be‐
ing replaced, improvements may not be achieved as a result of joint replacement alone in
patients who have multiple joint arthropathy or systemic health issues. Functional outcomes
also seem to be dependent on the site of joint replacement (Table 2). Consistent with pain
outcomes, a higher proportion of patients undergoing TKR report poor function or difficulty
with activities than do patients undergoing THR. Demographic and patient characteristics
are of predictive value in determining barriers to functional gain and activity participation
following TJR recipients.
3. Predictors of pain and function
Intuitively, those who present with the “worst” symptoms might be those who should be
prioritized for TJR. However, the literature reports a mismatch between patient reported
symptom severity and response to surgery and it is becoming clearer that TJR outcomes are
influenced by a multitude of factors. Recent work has identified a number of baseline risk
factors for continuing pain and disability after TJR and these can be stratified into those
which are modifiable and non-modifiable.  Non-modifiable risk factors include; age, gen‐
der, socio-economic status, aetiology and culture and ethnicity. Modifiable risk factors in‐
clude; psychological state, co-morbidities, obesity, baseline symptom severity and patient
expectation.
Importantly, our work to date has demonstrated that a majority of baseline patient charac‐
teristics (obesity, mental health, co-morbidities, radiographic OA severity, baseline pain and
function) associated with sub-optimal outcome following TJR are those that could be “modi‐
fied” with appropriate intervention [8, 39, 40, 65]; hence there is opportunity to alter patient
outcomes. Appreciating the nature of patient pre-operative risk factors and the impact of
different outcomes is critical for improving response rates to surgery.
3.1. Patient demographics
3.1.1. Age
As age is the strongest predictor of the development and progression of osteoarthritis the
ageing population has no doubt contributed to the world wide increase in TJR numbers.
However, TJR in younger patients is also on the rise particularly for knee replacement [66],
and this is likely due in part to the rising incidence of obesity in patients presenting for sur‐
gery [8, 39]. The median age at presentation for joint replacement demonstrates a downward
trend over the past 10 years at our institution (Figure 1)
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Figure 1. Median age at presentation for primary elective TJR (SVHM JRR)
Total joint replacement in the elderly carries a higher risk of peri-operative complication, re‐
quires a longer recovery time and is associated with a significant mortality rate in the longer
term [67, 68]. However advancing age is not a barrier to pain and functional improvements
after TJR surgery [67, 68] and excellent pain relief has been reported in individuals in their
80’s and 90’s [69-71]. While advancing age is associated with poorer function and activity
levels following TJR [40] higher satisfaction with activity levels have been reported in those
older than 70 years when compared to their younger counterparts [72].
3.1.2. Gender
Worldwide more females than males undergo joint replacement each year, with the greatest
difference being for knee replacement. Various National Joint Replacement Registries report
the ratio of females to males undergoing knee replacement as high as 2:1 and this concurs
with gender patterns at our institution (Figure 2), [73-76]. Despite these figures inequities in
referral patterns and reluctance in women to undergo joint replacement, resulting in late
presentation have been reported [77, 78]. A gender bias in physician referral for knee re‐
placement was identified in one study, with family physicians twice as likely and orthopae‐
dic surgeons 22 times more likely to recommend knee replacement to male patients [79].
However it has also been identified that women delay seeking joint replacement until a later
point in their functional decline [77].
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Figure 2. Gender breakdowns at presentation for primary elective TJR (SVHM JRR)
Females generally present with worse self-reported pain and functional impairment compared
to males at the time hip and knee replacement [80-83], as such females do not tend to achieve
the same level of physical function after surgery as males [84, 85]. However when taking into
account baseline pain and function, women generally demonstrate greater improvements in
pain and function scores after surgery than men [84-86]. Faster recoveries in terms of pain and
function have also been reported in females undergoing total knee replacement when com‐
pared to males [87]. Despite this a significantly higher odds of poor function at 12 months (OR
1.81; 95% CI 1.08-3.03) and 2 years (OR 2.06; 95% CI 1.20 – 3.53) post knee replacement have
been reported by women undergoing TKJR [40]. Impairment with specific activities such as
stair climbing, despite achieving greater improvements in knee flexion, have also been report‐
ed in females compared to males [86]. These data suggest women may benefit from tailored re‐
habilitation programs following joint replacement surgery.
3.1.3. Socio-economic status
Differences among nations in their socio-economic fabric, ethnic composition, health care
systems and cultural expectations, may confound studies examining the importance of soci‐
oeconomic status as a predictor of outcome following TJR. Variations in classifications of so‐
cio-economic status also require that caution should be exercised in making direct
comparisons between studies. To date studies have largely focused on socio-economic status
in patients undergoing total hip replacement, with most data derived from cohorts in West‐
ern countries.
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A large UK study by Jenkins et.al (2009) reported significant differences in SF-36 physical
improvement between the least and most “deprived groups” 18 months post THR [88]. A
study based in Scotland by Clement et.al (2011) reported similar findings. In a cohort of 1312
patients who underwent primary THR a significant improvement in Oxford scores across all
socioeconomic categories was noted, however social deprivation predicted a poorer func‐
tional outcome [89]. In a smaller study based in the US, Allen-Butler et.al (2011) conducted a
secondary analysis of a prospective randomised study originally comparing 2 different hip
stems. They also concluded that individual socioeconomic parameters such as education
level, household income, as well as being African American were associated with lower
Harris Hips Scores up to 2 years post THR [90]. Finally a German based study by Schafer
et.al (2010) also concluded that socioeconomic parameters independently predicted re‐
sponse to THR as measured using the WOMAC [91]. An increased risk for “non-response”
to surgery at 6 months was demonstrated in widowed patients, those who lived alone, those
on a disability pension and those who had a shorter duration of school education.
Only one study reported outcomes according to socioeconomic status in patients undergo‐
ing total knee replacement. In a multicentre study conducted in several countries (USA, UK,
AU, Canada) socio-economic status did not appear to affect the outcome of knee replace‐
ment [92]. Socioeconomic data were derived from a pre-operative questionnaire regarding
education, income, working status and living arrangements, to allow for direct comparison
between countries. Despite reporting a correlation between lower income and worse pre-op‐
erative pain and function, there were no differences in post-operative pain and function at
24 months.
Despite variations in definitions and study designs, patient reported outcomes following
THR are consistently poorer for disadvantaged groups. In contrast there is a dearth of litera‐
ture on TKR with only one study that reported no differences in patient reported outcomes.
Poorer outcomes in socioeconomically disadvantaged groups may occur as a result under‐
utilization of health services [93] and this has important implications in relation to preparing
disadvantaged patients for joint replacement surgery.
3.1.4. Culture and ethnicity
Racial and ethnic TJR utilization disparities exist and are likely due to a lower willingness to
undergo surgery amongst ethnic minorities rather than lower disease prevalence [78, 94, 95].
Poor health literacy, financial constraints, cultural influences and concerns about possible
outcomes are amongst reported reasons for a lower willingness to undergo surgery and de‐
layed presentation [96-100]. As such self-reported baseline pain and function are worse
amongst ethnic minorities presenting for total joint replacement surgery [100-103].
Substantial improvements in pain and function have been reported following primary to‐
tal  joint  replacement irrespective of  race and ethnicity  however ethnic  minorities  do re‐
port  worse  outcomes  following  both  hip  and  knee  replacement  surgery.  Lavernia  et  al
(2011) studied patient reported outcomes in a large cohort of hip and knee replacements
(739 hips and 1010 knees) and found that ethnic minorities had worse pain, function and
well-being  scores  2  years  after  surgery  compared  to  Whites  and  worse  outcomes  was
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most pronounced for African Americans [103]. Kamath et al (2010) reported similar find‐
ings for African-Americans undergoing TKJR [100]. In an Australian study of 237 TKR’s,
41 were non-English speaking patients, Dowsey et al (2009) reported poorer International
Knee Society pain and function scores at 12 months after surgery in those who required
Interpreters compared to their English speaking counterparts[104]. A Swedish study ana‐
lysed 1216  patients’  pre  and 1  year  after  THR,  comparing those  who were  born  inside
and outside the country.  Krupic et  al  (2012) reported lower self  care and activity scores
and more pain amongst those born abroad [102].
Promoting greater dialogue with health care providers and understanding the health litera‐
cy needs of ethnic minorities may help to address willingness to undergo joint replacement
surgery and lead to better patient reported outcomes [105, 106].
3.2. Patient characteristics
3.2.1. Aetiology
Osteoarthritis is the principle diagnosis for a majority of total joint replacements performed
each year [73-76]. In Australia it accounted for 88% of primary elective total hip replacement
and 97% of primary elective knee replacement in 2010 [73]. The remaining diagnoses for
elective THR included avascular necrosis (3.7%), dysplasia (1.3%) and rheumatoid arthritis
(1.3%) and for TKR; rheumatoid arthritis (1.7%), inflammatory arthritis (0.5%) and necrosis
(0.4%) [73].
Despite the worldwide increase in TJR numbers in recent years, the rate of joint replacement
surgery in patients with rheumatoid arthritis has remained relatively stable and for some
countries a decrease in numbers has been noted [107-110]. Contemporary treatment of rheu‐
matoid arthritis now includes disease modifying medications or biologics, anti-tumour ne‐
crosis factor drugs and corticosteroids are proving to be more effective in the management
of this immune disease when taken in combination as opposed to mono-therapy [111]. De‐
spite advances in conservative management of rheumatoid arthritis, joint replacement re‐
mains a viable treatment option for those with significant joint pain and stiffness although
joint destruction, osteoporosis and severe deformity make surgery technically challenging in
this group [110]. Nevertheless rheumatoid patients demonstrate substantial improvements
in pain, function and quality of life following TJR [112-115]. Although functional outcomes
after surgery are inferior, rheumatoid patients report equivalent pain relief from TJR when
compared to OA patients[110].
Aside from rheumatoid arthritis total hip replacement in young adults is generally reserved
for those with developmental dysplasia (DDH) and slipped upper femoral epiphysis
(SUFE). Anatomical abnormalities including acetabular or femoral deformity, leg length dis‐
crepancy and the age at which joint replacement is performed can contribute to higher fail‐
ure rates observed in these patient compared to patients with osteoarthritis [73, 116, 117].
Setting aside the higher likelihood of revision surgery for patients who have hip replace‐
ment for DDH or SUFE in the longer term, post-operative outcome scores for these patients
are comparable to patients with OA in the short term. No significant differences in Oxford
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hips scores at 6 months have been observed in THR patients with either DDH or SUFE when
compared OA patients [118, 119]. Excellent functional outcomes have also been reported in
patients with DDH under the age of 30 years with an average Harris Hips score of 90.6 at 9
[3-14] years follow-up [117]. Similar Harris Hip Scores (average 93) have been reported in
THR for SUFE at 15 years follow-up [120].
3.2.2. Co-morbidities
Individual comorbidities such as diabetes, cardiovascular and respiratory disease are com‐
monly reported in patients undergoing TJR and many patients carry multiple comorbidities
[7, 8, 39, 40, 121]. When reported as a composite, self-reported functional outcomes are poor‐
er in patients with multiple comorbidities for both hip and knee replacement. Lingard et al
(2004) reported an association with higher comorbidity and poorer SF-36 physical function
scores at 1 year after knee replacement [122] and Gandhi et al (2010) reported similar find‐
ings at 3 [1–8] years [123]. In total hip replacement Young et al (2008) reported better func‐
tional outcomes following hip replacement in those had no comorbid disease [124].
Deyo-Charlson comorbidity index, a validated clinical comorbidity index [125] is an inde‐
pendent predictor of functional outcome in TJR. Singh & Lewallen (2010) studied activity
limitation and dependence on walking aids in both hip and knee replacement patients 2 and
5 years after surgery. Deyo-Charlson comorbidity index independently predicted a greater
reliance on walking aids at 2 and 5 years after both total hip and knee replacement and high‐
er odds of moderate to severe activity limitation at 2 years after knee replacement [64, 126].
We have reported similar findings in patients undergoing TKR using an Age-Adjusted
Charlson Comorbidity Index [127], demonstrating higher odds of reporting poor function at
2 years in those with a higher comorbidity index [40].
Very little is known about the effect of individual comorbidities on patient reported out‐
comes in TJR. A recent study of 677 consecutive primary knee and 547 consecutive primary
hip replacements, demonstrated an association between metabolic syndrome risk factor and
1 year WOMAC scores [128]. Metabolic syndrome risk factors were self-reported and de‐
fined as body mass index >30kg/m2, hypercholesterolemia, hypertension and diabetes.
While increasing number of metabolic risk factors were associated with higher (worse) WO‐
MAC scores, individual risk factors were found to better predict outcome. Obesity predicted
higher WOMAC scores in both total hip and total knee replacement and hypertension also
predicted higher WOMAC scores in total hip replacement only.
3.2.3. Obesity
Obesity features prominently in the patho-physiological mechanisms underpinning OA es‐
pecially end-stage OA requiring TJR [129]. Obesity affects 1 in 4 members of the community,
but our data indicate a 2-3 fold over-representation of obesity in patients presenting for TJR
(Figure 3). The economic impact of obesity-related OA in Australia was estimated to be
$221.3 million in 2005 [130]. While the real costs of treating obese patients with TJR remain
unknown, we have demonstrated higher episode of care costs for TKR in the first 12 months
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(+$1,821[95% CI $245, $3,398]; p=0.024) in a comparative cohort of 520 patients [131]. The
cost of THR is also estimated to be higher for obese ($523) and morbidly obese patients,
($1,432) patients [132]. In addition to the increasing overrepresentation of obese patients pre‐
senting for TJR (Figure 3) our data demonstrates that the severity of obesity is also increas‐
ing over time (Figure 4), as such developing strategies to reduce the burden of obesity-
related joint disease should be an imperative [133].
Weight loss in obese patients awaiting TJR is a problem because the symptoms of disabling
arthritis may limit an individual’s ability to exercise. Patients often identify this as the rea‐
son for the inability to lose weight, and believe that joint replacement would be critical for
weight loss. However, numerous studies have confirmed that undergoing total joint replace‐
ment does not result in clinically significant weight loss and as many as one-third of patients
gain weight at 12 months after surgery [8, 39, 134-140]. It has also been demonstrated that
weight gain continues to increase over time after joint replacement [141].
Figure 3. Obesity rates in OA patients at presentation for primary elective TJR (SVHM JRR)
Data from our registry demonstrates that both the number of obese patients presenting for
joint replacement (Figure 3) and the average BMI of patients is increasing over time, particu‐
larly in the past 5 years. Of note there are higher rates of obesity and a more rapid rise in
average BMI demonstrated amongst recipients of knee replacement compared to recipients
of hip replacement, with females undergoing knee replacement recording the highest BMI
average.
Arthroplasty - Update78
Figure 4. Mean BMI of OA patients at presentation for primary elective TJR (SVHM JRR)
Although widely reported there remains disagreement in the literature as to the impact of
obesity on patient reported outcomes following TJR. Numerous reviews confirm that obese
patients report substantial improvements in pain and function following joint replacement
surgery [142-145]. However when limited to level 1 studies [146], the evidence does suggests
that obese and particularly morbidly obese patients may not achieve the same level of func‐
tional improvement after TJR when compared to non-obese patients in both the short and
longer term.
3.2.3.1. Outcomes for primary THR
Obesity and advancing BMI have been shown to have a negative impact on pain and more
so function after primary elective total hip replacement in both the short and longer term.
Functional gains and activity levels after THR remain poorer for obese when compared to
non-obese individuals. Obese groups also report worse pain and higher usage of pain medi‐
cation after THR. A review of level 1 large cohort studies is presented.
Moran et al (2005) compared functional and QoL outcomes using the Harris Hip Score
(HHS) and Short-Form-36 (SF-36) in 800 patients undergoing total hip replacement, pre sur‐
gery (100% follow-up) and at 6 (97% follow-up) and 18 months (86% follow-up) [147]. BMI
was found to be a significant predictor of poorer function at both 6 and 18 months. The au‐
thors concluded that the difference between obese and non-obese scores were small and
therefore not clinically significant, however this was based on comparing post-operative
scores only and the change in scores between groups was not provided.
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Gandhi et al (2010) investigated the influence of self-reported metabolic syndrome risk fac‐
tors defined as obesity, hypertension, hypercholesterolemia and diabetes on patient function
in a consecutive cohort of 547 primary hip replacements [128]. As measured using the WO‐
MAC obesity was associated with higher odds (2.4; 95% CI 1.4 – 4.2) of less functional im‐
provement at 12 months after surgery.
Dowsey et al (2010) compared pain, function (HHS) and quality of life (SF-12) in a consecu‐
tive cohort of 471 primary THR’s with 98.5% follow-up. Function and physical health scores
were worse at baseline and 12 months after surgery for obese and morbidly obese patients.
Baseline mental health scores were also worse in obese and morbidly obese patients, howev‐
er were comparable at 12 months with obese patients demonstrating a significantly greater
improvement in scores compared to non-obese patients [39].
Lubbeke et.al (2007) reported significantly poorer functional outcomes in obese patients
(n=182), who underwent primary THR compared to non-obese patients (n=635), at 5 years
follow-up, as measured using the Harris Hip Score [148]. Eighty-one percent of hips in the
non obese group and 70% in the obese group had a good to excellent results according to
their HHS. When broken down by gender it was obese females who demonstrated signifi‐
cantly poorer outcomes compared to non-obese females with very little differences in out‐
comes demonstrated between obese and non obese males.
Singh & Lewallen (2010) measured activity limitation and dependence on walking aids in
5,707 patients at 2 years and 3,289 patients at 5 years after primary total hip replacement
[64]. Predictors of moderate to severe activity limitation (defined as limitation in 3 or more
activities), included BMI > 30kg/m2 at both time intervals. Obese (BMI > 30kg/m2) patients
had higher odds of complete dependence on a walking aid at 2 years and severely obese
(BMI >35kg/m2) had a higher odds of complete dependence on a waking aid at 5 years.
Singh & Lewallen (2010) also examined pain as measured by the Mayo Hip Score and the
use of pain medications at 2 and 5 years following primary total hip replacement in the
same cohort of patients [46]. The odds of reporting ongoing moderate to severe pain at 2
years after surgery were higher in those with a BMI 35-39.9kg/m2 (OR 1.8; 95% CI 1.2 – 2.4)
and BMI > 40kg/m2 (1.7; 95% CI 1.0 – 2.9) compared to those with a BMI < 25kg/m2. At 5
years the odds of reporting ongoing moderate to severe pain was higher for all weight
groups compared to the baseline group; BMI 25 – 29.9kg/m2, (OR 1.5; 95% CI 1.1 – 2.1); BMI
30-34.9kg/m2, (OR 1.8; 95% CI 1.2 – 2.6); BMI 35-39.9kg/m2, (OR 1.9; 95% CI 1.2 – 3.1); and
BMI > 40kg/m2, (OR 3.1 95% CI 1.7 – 5.7). BMI 35-39kg/m2 was also a predictor of non-steroi‐
dal anti-inflammatory use at 2 years and BMI 30-34.9kg/m2 predicted use of opioid medica‐
tion at 5 years after THR.
3.2.3.2. Outcomes for primary TKR
Obesity and advancing BMI have been shown to have a negative impact on function after
primary elective total knee replacement in both the short and longer term. Functional gains
and activity levels after TKR are poorer for obese when compared to non-obese individuals.
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Obese groups however do report comparable pain outcomes compared to non-obese pa‐
tients after surgery. A review of level 1 large cohort studies is presented.
Gandhi et al (2010) investigated the influence of self-reported metabolic syndrome risk fac‐
tors defined as obesity, hypertension, hypercholesterolemia and diabetes on patient function
in a consecutive cohort of 677 primary knee replacements with 83% follow-up [128]. As
measured using the WOMAC, obesity (BMI > 30kg/m2) was associated with higher odds
(3.6; 95% CI 0.02 – 7.2) of less functional improvement at 12 months after surgery.
Rajgopal et al (2008) compared functional outcomes between morbidly obese (BMI >
40kg/m2) and non-morbidly obese (BMI < 40kg/m2) patients 12 months after total knee re‐
placement in a series of 550 patients; of which 69 patients were classified as morbidly obese
[149]. BMI ≥ 40 predicted 12 month WOMAC scores (coefficient −5.188, 95% CI −9.771
−0.606), however no differences in the change in WOMAC or SF-12 scores were demonstrat‐
ed when comparing morbidly obese to non-morbidly obese patients.
We also measured improvement in pain, function and quality of life from baseline to 12
months following elective primary knee replacement in consecutive series of 529 patients
with 98% follow-up [8]. The change in IKSS function scores were 10 points lower for both
obese (BMI > 30kg/m2) and morbidly obese (BMI > 40kg/m2) patients compared to non-
obese (BMI <30kg/m2), (p=0.002). No significant difference in IKSS pain scores was noted be‐
tween the 3 groups at baseline or 12 months and there was no significant difference in SF-12
scores between the 3 groups at baseline or 12 months.
Singh et al (2010) measured activity limitation in 4,701 patients at 2 years and 2,395 patients
at 5 years after primary knee replacement [126]. Predictors of moderate to severe activity
limitation (defined as limitation in 3 or more activities), included all BMI groups > 30 com‐
pared to BMI < 25kg/m2 at 2 years after surgery; BMI 30-34.9kg/m2, (OR 1.5; 95% CI 1.0 – 2.0);
BMI 35-39.9kg/m2, (OR 1.8; 95% CI 1.3 – 2.7); and BMI > 40kg/m2, (OR 3.0 95% CI 2.0 – 4.5).
Higher BMI also predicted moderate to severe activity limitation at 5 years; BMI
35-39.9kg/m2, (OR 2.1; 95% CI 1.4 – 3.3); and BMI > 40kg/m2, (OR 3.9 95% CI, 2.3 – 6.5).
Sing et al (2011) also examined whether BMI was associated with pain as measured using
the IKSS after primary knee replacement at 2 and 5 years after surgery [150]. Patients were
classified into BMI groups as above for comparison. In contrast to their study on activity
limitation, there was no association demonstrated between BMI and ongoing moderate to
severe pain at either 2 or 5 years after TKR.
Our findings mirror that of Singh et al (2010 & 2011). We reported pain and function out‐
comes in a cohort of 478 consecutive primary elective total knee replacements at 1 and 2
years post surgery with 99% and 94% follow-up respectively [40]. Each incremental increase
in BMI significantly increased the odds of poor function as measured using the IKSS at 12
months (OR 1.07, 95% CI 1.03 – 1.12) and at 2 years (OR 1.09, 95% CI 1.05 – 1.14). However
we found no association between advancing BMI and ongoing moderate to severe pain at
either time point.
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3.2.4. Psychosocial state
Psychological distress leading to patient dissatisfaction after TJR is an important cause for
TJR failure. Pre-operative psychological distress is associated with excessive analgesic intake
and higher rates of hospital readmission and long term mortality [151]. Our research has al‐
so drawn a link between poorer pre-operative mental health and weight gain after TJR [39].
Published results from the SVHM TJR cohort and that of others have i) identified a high rate
(30-60%) of self-reported psychological distress in TJR patients [152-154] and ii) determined
that pre-operative psychological distress is an independent risk factor for poorer post-opera‐
tive outcomes after surgery [8, 65]. A number of recent comprehensive literature reviews
have found pre-operative psychological distress to be an independent predictor of pain and
function after TKR in a majority of published studies [155, 156].
Psychological co-morbidities and traits reported in TJR patients include; anxiety, depression,
neuroticism, catastrophising and poor self-esteem. These individual traits and poorer pre-
operative mental health scores in general are associated with poorer function and/or greater
pain after TJR in the short and longer term.
In general pre-operative psychological distress is associated with poorer pain and worst
function 1 year after total joint replacement. We have reported an association between lower
SF-12 MCS scores and risk for ongoing moderate to severe pain and poor function at 12
months and 2 years following TKR. Lingard et al (2004) also reported an association be‐
tween lower SF-36 MCS scores and worse WOMAC pains scores at 1 and 2 years after TKR
[122]. An analysis of pre-operative and one-year post-operative data in 6,158 patients from
the Swedish Hip Arthroplasty Register, also demonstrated that anxiety/depression meas‐
ured on the EQ-5D [157] was a strong predictor of pain after THR [158].
Anxiety is a psychological and physiological state characterized by somatic, emotional, cog‐
nitive, and behavioural components [159]. Anxiety can occur as a result of transient negative
stimuli such as in a threatening situation and this is referred to as state anxiety. In contrast
trait anxiety is referred to as a general tendency to experience anxiety [160]. In patients un‐
dergoing total hip replacement trait anxiety has shown to correlate with impaired health re‐
lated quality of life 3 to 6 months after surgery [161, 162]. In contrast state anxiety had no
effect on outcome suggesting pre-existing anxiety disorder rather than anxiety induced by
fear of surgery predicts poorer outcomes form joint replacement.
Pre-existing depression has been shown to predict greater pain and poorer function in pa‐
tients undergoing total knee replacement at 1 year and it has also been demonstrated that
worse outcomes persist at 5 years [20, 163]. However this finding is not consistent, with
some studies suggesting that there is no association between depression measured prior to
surgery and pain and function outcomes following TJR. Of note Riddles et al (2010) meas‐
ured the association between a range of psychological comorbidities including depression,
anxiety and panic disorders, self efficacy and fear of movement and found that only pain
catastrophising predicted poorer pain outcomes after total knee replacement [164],
Pain catastrophising has been described as a tendency to magnify or exaggerate the threat
value or seriousness of pain sensations [165]. Pre-operative pain catastrophising is a predic‐
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tor of worse post-surgical pain following TKR in the short (6 weeks and 6 months) term, but
does not correlate with function [164, 166]. The correlation between catastrophising and
poorer post-operative pain has also been shown to persist at 24 months following TKR [167].
To date the link between pain catastrophising and post operative pain after TJR seems to be
unique to knee replacement, with no evidence of pain catastrophising in total hip replace‐
ment patients.
Neuroticism is a personality trait described as an enduring tendency to experience negative
emotional states [168]. There is a dearth of literature examining the association between neu‐
roticism and TJR, however one study on total hip replacement did report that neuroticism
was amongst a number of psychological traits that predicted poorer quality of life outcomes
at 6 months after surgery [162].
3.3. Baseline symptom severity
Total joint replacement is most often performed for the management of “end-stage’ arthritis
characterised by retractable pain, loss of function and deformity [30]. According to the NIH
statements for both hip and knee replacement, candidates for elective TJR should have ra‐
diographic evidence of joint damage, moderate-to-severe persistent pain that is not ade‐
quately relieved by an extended course of nonsurgical management, and clinically
significant functional limitation resulting in diminished quality of life [32, 33]. However
there is discordance between radiographic changes and patient reported symptom severity
at presentation for surgery, with some people receiving joint replacement reporting severe
preoperative symptoms of pain and disability and mild radiographic changes [80, 83].
3.3.1. Baseline clinical symptoms
Baseline symptom severity is a predictor of outcome for both total hip and knee replace‐
ment. Several studies have concluded that those with worse pain and poor function at the
time of surgery also report comparatively worse pain and function after surgery, suggesting
that surgery could be prioritized based on clinical symptom severity [169].
In a multicentre study involving more than 200 hip and knee replacements Fortin et al
(1999] reported that lower preoperative physical function scores predicted worse WOMAC
pain and function at 6 months compared to those with higher baseline function scores [170].
Fortin et al (2002) continued to follow the cohort up at 2 years post surgery and confirmed
that their initial findings at 6 months persisted [169], concluding that undergoing surgery
earlier in the course of functional decline may be associated with better outcome.
In a larger study involving 860 recipients of primary TKR from 3 different countries, Lin‐
gard et al (2004) reported that worse baseline WOMAC pain scores were a strong determi‐
nant of worse pain at 1 and 2 years after surgery. Pre-operative WOMAC function was also
the strongest predictor of worse function at both 1 and 2 years after surgery [122].
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3.3.2. Baseline radiographic characteristics
In contrast to clinical symptoms emerging literature suggests that those with the worst ra‐
diographic OA symptoms report better outcomes after total joint replacement.
We recently evaluated the association between pre-operative radiographic changes and out‐
comes after primary total knee replacement for osteoarthritis. We reported that pain relief
was unsatisfactory in about 30% and functional improvement suboptimal in about 50% of
patients [40]. In this study radiographic OA severity was measured using a modified ver‐
sion of the Kellgren-Lawrence Classification system [80]. We noted that radiographic OA se‐
verity was an independent predictor of pain and function at 12 months following TKR.
Patients with evidence of mild radiographic OA changes were 5 times more likely (OR 5.39,
95% CI 1.23 – 15.69) to report moderate to severe pain at 12 months post TKR than those
with severe radiographic changes.
Merle-Vincent et al (2011) examined predictors of satisfaction in 299 patients undergoing
primary TKR and reported an association between radiographic OA severity and outcome 2
years after surgery [171]. Those with severe pre-operative joint space narrowing were nearly
4 times more likely to report satisfaction with surgery at 2 years compared to those with
mild to moderate narrowing, (OR 3.9, 95% CI 1.1 – 14.3).
Valdes et al (2012) examined predictors of chronic pain using the WOMAC in 860 patients
who had undergone TKR and 928 patients who had undergone THR with an average of 3.2
years follow-up [172]. They reported an OR 1.56 (95% CI 1.04 – 2.36) of ongoing pain in TKR
patients with a Kellgren-Lawrence grade <3 and in THR patients with minimal joint space
narrowing (>2mm width).
Cushnaghan et al (2007) reported on long term (approximately 8 years) functional outcomes
following THR in a series of 282 patients matched with 295 community controls [173]. Ra‐
diographic OA severity defined as Croft grade 5 OA[174] was a predictor of greater func‐
tional improvement in cases as measured using the SF-36 physical function scores (19.4, 95%
CI 7.7 – 31.2), when compared to cases with Croft grade < 3.
These findings suggest an inverse relationship between baseline radiographic OA and out‐
come up to 8 years following total joint replacement. More severe radiographic changes pre‐
dict worse pain and to a lesser degree suboptimal function after surgery, providing
important implications for timing of joint replacement.
4. Conclusion
Total joint replacement is the most effective and cost effective treatment for end-stage osteo‐
arthritis. Most patients derive substantial benefits from joint replacement surgery; however
those that don’t are subject to chronic pain and disability and a higher risk for revision sur‐
gery. The causes of poor outcomes of surgery are multifactorial but almost certainly patient
selection is a key determinant. While those who present with the “worst” symptoms might
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be those who should be prioritized for TJR, the literature reports a mismatch between pa‐
tient reported symptom severity and response to surgery. Although many risk factors are
recognised, their individual or combined contributions to the absolute risk of suboptimal out‐
come after TJR remains poorly quantified. Importantly a majority of baseline patient charac‐
teristics (obesity, mental health, co-morbidities, radiographic OA severity, baseline pain and
function) associated with sub-optimal outcome following TJR are those that could be “modi‐
fied” with appropriate intervention. However baseline risk factors tend to remain unidenti‐
fied or identified and managed at the point of surgery, which is too late. Hence there
remains a need for exploring early interventions where there is opportunity to alter patient
outcomes.
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